Diphenhydramine Dosing
For parenteral (IV/IM) administration, use 1-2 mg/kg or 25-50 mg per dose in both adults and children; for oral administration, adults should receive 25-50 mg every 4-6 hours (maximum 400 mg/day), while children receive weight-based dosing of 5 mg/kg/day divided into 4 doses (maximum 300 mg/day). 1, 2, 3
Parenteral Dosing (IV/IM)
The established guideline-based dosing for parenteral diphenhydramine is consistent across age groups when calculated by weight:
- Weight-based: 1-2 mg/kg per dose 1
- Adults: 10-50 mg per dose (up to 100 mg if required; maximum 400 mg/day) 2
- Children: 5 mg/kg/24 hours or 150 mg/m²/24 hours divided into 4 doses (maximum 300 mg/day) 2
Critical administration note: IV diphenhydramine should be administered at a rate not exceeding 25 mg/min to avoid potentially serious adverse effects including cardiac toxicity 2, 4. Rapid IV administration has been associated with life-threatening complications.
Oral Dosing
Adults and children >12 years: 25-50 mg (10-20 mL of standard solution) every 4-6 hours, not exceeding 6 doses in 24 hours 3
Children 6 to <12 years: 25 mg (10 mL) every 4-6 hours 3
Children <6 years: Not recommended for over-the-counter use 3
Clinical Context and Important Caveats
Diphenhydramine is second-line therapy to epinephrine in anaphylaxis and should never be used alone for this indication 1. The guidelines consistently emphasize that H1-antihistamines have a much slower onset of action than epinephrine and are adjunctive therapy only.
Key Pitfalls to Avoid:
Rapid IV administration: Always administer IV doses slowly (≤25 mg/min) to prevent cardiac arrhythmias and other serious adverse effects 2, 4
Overreliance in anaphylaxis: Diphenhydramine does not replace epinephrine and should not delay epinephrine administration 1
Age-related considerations: Pharmacokinetic studies demonstrate significantly prolonged half-life in elderly adults (13.5 hours) versus young adults (9.2 hours) and children (5.4 hours), though dosing adjustments are not routinely made 5
Sedation risk: First-generation antihistamines like diphenhydramine cause significant sedation (50% in some studies) and cognitive impairment, particularly problematic in elderly patients 6, 7
Evidence Quality Note:
While the anaphylaxis guidelines are from 2005 1, they remain the authoritative source from the Journal of Allergy and Clinical Immunology. The FDA labeling 2, 3 provides the regulatory standard for dosing. Recent evidence 8, 7 suggests clinical practice may be shifting away from diphenhydramine due to its side effect profile, with second-generation antihistamines preferred when appropriate, though the fundamental dosing recommendations remain unchanged.
Combination therapy: When used in anaphylaxis, combining diphenhydramine with an H2-antagonist (ranitidine 1 mg/kg or cimetidine 4 mg/kg) is superior to diphenhydramine alone 1.